>>> US Research Calls I

Research Calls I
  • Upgrades
    • Ameren (AEE) upgraded to Overweight from Sector Weight at KeyBanc, tgt $103
    • Carlyle (CG) upgraded to Buy from Hold at TD Cowen, tgt $56
    • Charles River (CRL) upgraded to Buy from Hold at TD Cowen, tgt $179
    • Chimera (CIM) upgraded to Buy from Neutral at UBS, tgt $15
    • Establishment Labs (ESTA) upgraded to Buy from Hold at Needham, tgt $48
    • Entergy (ETR) upgraded to Overweight from Sector Weight at KeyBanc, tgt $85
    • Franklin Resources (BEN) upgraded to Buy from Hold at TD Cowen, tgt $27
    • Funko (FNKO) upgraded to Neutral from Sell at Goldman, tgt $5.50
    • KKR (KKR) upgraded to Overweight from Equal Weight at Morgan Stanley, tgt $150
    • Omnicell (OMCL) upgraded to Overweight from Equal Weight at Wells Fargo, tgt $35
    • Perion Network (PERI) upgraded to Buy from Neutral at Roth Capital, tgt $14
    • PVH Corp. (PVH) upgraded to Buy from Hold at Jefferies, tgt $105
    • Regeneron (REGN) upgraded to Buy from Neutral at Citigroup, tgt $700
    • RTX (RTX) upgraded to Buy from Hold at The Benchmark Company; tgt $140
    • Sea Limited (SE) upgraded to Overweight from Neutral at JPMorgan, tgt $190
    • Ulta Beauty (ULTA) upgraded to Positive from Mixed at BWG Global
  • Downgrades
    • AbbVie (ABBV) downgraded to Neutral from Buy at Citigroup, tgt $205
    • Affimed (AFMD) downgraded to Neutral from Buy at H.C. Wainwright
    • Allogene (ALLO) downgraded to Market Perform from Outperform at Citizens JMP
    • Biodesix (BDSX) downgraded to Market Perform from Outperform at William Blair
    • Cboe Global Markets (CBOE) downgraded to Underweight from Overweight at Morgan Stanley, tgt $215
    • Consolidated Edison (ED) downgraded to Underweight from Sector Weight at KeyBanc, tgt $90
    • Exelon (EXC) downgraded to Underweight from Sector Weight at KeyBanc, tgt $39
    • Federated Hermes (FHI) downgraded to Hold from Buy at TD Cowen
    • Group 1 Auto (GPI) downgraded to Neutral from Buy at Guggenheim
    • Halozyme (HALO) downgraded to Equal Weight from Overweight at Morgan Stanley, tgt $62
    • iTeos Therapeutics (ITOS) downgraded to Neutral from Buy at H.C. Wainwright
    • iTeos Therapeutics (ITOS) downgraded to Market Perform from Outperform at Leerink, tgt $9
    • Lavoro (LVRO) downgraded to Underweight from Overweight at Barclays, tgt $1.50
    • Magnera (MAGN) downgraded to Equal Weight from Overweight at Wells Fargo, tgt $16
    • Merck (MRK) downgraded to Neutral from Buy at Citigroup, tgt $84
    • Nextracker (NXT) downgraded to Neutral from Buy at Guggenheim
    • Nutrien (NTR) downgraded to Sector Perform from Outperform at Scotiabank, tgt $62
    • Portland General (POR) downgraded to Sector Weight from Overweight at KeyBanc
    • Quipt Home Medical (QIPT) downgraded to Hold from Buy at Canaccord, tgt $1.70
    • Rivian (RIVN) downgraded to Hold from Buy at Jefferies, tgt $16
    • Southern Company (SO) downgraded to Underweight from Sector Weight at KeyBanc, tgt $78
    • UL Solutions (ULS) downgraded to Neutral from Buy at Citigroup, tgt $71
    • UnitedHealth (UNH) downgraded to Neutral from Buy at BofA Securities, tgt $350
    • UnitedHealth (UNH) downgraded to Market Perform from Strong Buy at Raymond James
    • Wayfair (W) downgraded to Sell from Hold at Loop Capital, tgt $35
    • Wendy's (WEN) downgraded to Neutral from Buy at Guggenheim
  • Others
    • Centrus Energy (LEU) initiated with an Outperform at Evercore ISI, tgt $145
    • Dutch Bros (BROS) initiated with an Outperform at RBC Capital, tgt $83
    • EHang (EH) initiated with a Buy at BofA Securities, tgt $26
    • Enova International (ENVA) initiated with a Buy at Seaport Research Partners; tgt $124
    • EZCORP (EZPW) initiated with a Neutral at BTIG Research
    • Forge Global (FRGE) assumed with Neutral from Underweight at JPMorgan, tgt $18
    • Hut 8 (HUT) initiated with a Buy at B. Riley Securities, tgt $25
    • SAB Biotherapeutics (SABS) assumed with a Buy at H.C. Wainwright, tgt $10
    • Solaris Energy Infrastructure (SEI) initiated with a Buy at Vertical Research; tgt $36
    • Vitesse (VTS) resumed with a Buy at Alliance Global Partners; tgt $26